Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, GlaxoSmithKline Consumer Healthcare has informed about the details of Analyst / Institutional Investors Meeting to be held on Thursday, August 9, 2018.
The above information is a part of company’s filings submitted to BSE.